Breaking News, Promotions & Moves

CURE Pharmaceutical Appoints CFO

Alex Katz has worked with seed, early-stage and growth companies in diverse leadership capacities for 30 years

CURE Pharmaceutical has appointed Alex Katz to be the company’s chief financial officer. Bringing his expertise in venture capital, Katz will oversee the company’s financial functions and investment relations. “Our company is approaching 2019 amidst exponential growth and a clear vision to be a leader in drug delivery innovation,” said Robert Davidson, chief financial officer and chairman of the board of CURE Pharmaceutical. “Alex brings a deep breadth of financial leadership to our growi...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters